Use of anti-CD1 antibodies for the modulation of immune responses
The invention provides methods for the administration of an anti-CD 1 antibody for the treatment or prevention of a variety of disorders, such as autoimmune disease, viral infection, bacterial infection, parasitic infection, infection by a eukaryotic pathogen, allergy, asthma, inflammatory condition, graft versus host disease, graft rejection, immunodeficiency disease, spontaneous abortion, pregnancy, and cancer.
1. A method of treating a mammal having cancer, said method comprising administering to said mammal an anti-CD1d antibody or antibody fragment having the ability to bind CD1d in an amount sufficient to treat said cancer, wherein said antibody or antibody fragment is capable of activating antigen presenting cells that express CD1d.
2. The method of claim 1 , wherein said mammal is a non-rodent mammal.
3. The method of claim 2 or 1 , wherein said administration is intramuscular, intravenous, intraarticular, intralesional, subcutaneous, or intraperitoneal.
4. The method of claim 2 or 1 , wherein said antibody is administered with a pharmaceutically suitable carrier.
5. The method of claim 2 or 1 , wherein said mammal is a human.
6. The method of claim 2 or 1 , further comprising administering IL-12 to said mammal.